Yoshinori Kato, Ph.D.
Assistant Professor

Degrees
March 2002 Hoshi University, Graduate School of Pharmaceutical Sciences (Tokyo, Japan), Pharmaceutics, Ph.D. (Pharmaceutical Sciences)
March 1999 Hoshi University, Graduate School of Pharmaceutical Sciences (Tokyo, Japan), Pharmaceutics, Master (Pharmaceutical Sciences)
March 1997 Hoshi University, Faculty of Pharmaceutical Sciences (Tokyo, Japan), Bachelor of Pharmaceutical Sciences

Affiliation
Russell H. Morgan Department of Radiology and Radiological Science
JHU In vivo Cellular Molecular Imaging Center (ICMIC) Program
Department of Oncology at JHU
Institute for NanoBioTechnology at JHU

Research Areas of Interest
Drug delivery systems; Nanocarriers; Cancer chemotherapy; Molecular imaging in cancer; Development of theranostic agents

Honors and Awards

•  The Nagai Foundation Tokyo APSTJ graduate student award (March 1999)
•  The Nagai Foundation Tokyo APSTJ graduate student award (March 2001)
•  The Nagai Foundation Tokyo APSTJ graduate student award (March 2002)
•  Educational Stipends for Students and Postdoctoral Trainees, ISMRM, Travel Award (May 2004)
•  PSWC2004 Student Travel Grant (May 2004)
•  Scholar-in-Training Award, AACR Special Conference “Anti-Angiogenesis and Drug Delivery to Tumors: Bench to Bedside and Back” (November 2005)
•  Selected for Highly Rated Abstract (Top 3-4%) in 100th Annual Meeting of American Association for Cancer Research (Denver, CO)
  

Publications
Five selected articles from over 25 publications.

• Kato Y., Onishi H., Machida Y. Application of chitin and chitosan derivatives in the pharmaceutical field. Curr Pharm Biotechnol 4(5), 303-309 (2003).
• Yamabe K., Kato Y., Onishi H., Machida Y. Potentiality of double liposomes containing salmon calcitonin as an oral dosage form. J Control Release 89(3), 429-436 (2003).
  
• Kato Y., Onishi H., Machida Y. N-Succinyl-chitosan as a drug carrier: Water-insoluble and water-soluble conjugates. Biomaterials 25(5), 907-915 (2004).
  
• Kato Y., Artemov D. Monitoring of release of cargo from nanocarriers by MRI/MRS: Significance of T2/T2* effect of iron particles. Magn Reson Med 61, 1059-1065 (2009).
  
• Kato Y., Holm A.D., Okollie B., Artemov D. Noninvasive detection of temozolomide in brain tumor xenograft by magnetic resonance spectroscopy. Neuro-Oncology Advance Access published on October 20, 2009. doi:10.1093/neuonc/nop006.
  

Research Support
Ongoing and completed research support as Principal Investigator.

• R21 EB008162-01 (06/01/08-05/31/10)
  NIH/NIBIB
• Title: Noninvasive Monitoring of In Vivo Drug Release
  Research grant (04/01/08-03/31/09)
  The Nagai Foundation, Tokyo
  Title: Visualization of In Vivo Release Characteristics and Intratumoral Distribution of Anticancer Drug-Loaded Nanoparticles
  

Contact Information
217 Traylor Bldg.
720 Rutland Ave.
Baltimore, MD 21205, USA.
Phone: +1-443-287-4426
FAX: +1-410-614-1948
E-mail: ykato@mri.jhu.edu